Q1 results beat plan; EPS raised to high end of guidance
Solventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.
Buzzberg readQ1 results beat plan; EPS raised to high end of guidanceSolventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.Read full analysisCollapse analysis
Solventum's Q1 results exceeded expectations, driven by strong commercial execution and new product launches. Management reiterated full-year guidance while providing color on a significant ERP-driven Q2 sales pull-forward and continued portfolio optimization. Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.
Full-year EPS guidance raised to high end of $6.40-$6.60 range while maintaining top-line and margin guidance.
Expecting over $100M sales pull-forward into Q2 from Q3 ERP cutover; will be reversed in Q3.
Portfolio optimization continues with strategic tuck-in acquisitions (Acera) and ongoing P&F divestiture.
Revenue$2.007B
+0% QoQ
EPS$1.48
-6% QoQ
Gross margin54.66%
reported
Op margin4.04%
reported
What changed this quarter
01
Guidance
Q1 results beat plan; EPS raised to high end of guidance
Guidance tone
02
Macro
Tariff headwinds expected at $100-120 million annually
Q1 organic growth 2.1% beat expectations, led by volume; EPS of $1.48 up 11%.
03
Buybacks
Share buybacks to accelerate given undervalued shares
Full-year EPS guidance raised to high end of $6.40-$6.60 range while maintaining top-line and margin guidance.
04
Supply Chain
US ERP cutover to cause Q2 sales timing benefit over $100M
Expecting over $100M sales pull-forward into Q2 from Q3 ERP cutover; will be reversed in Q3.
AI, capex & demand read
AI
Platform & monetization
Management sees AI as a helpful tool for autonomous coding, differentiating on data, rules, and rigor. They report growing traction in outpatient and inpatient settings, with compelling economics for customers, and expect up to 50% of customers to adopt autonomous coding during the LRP period.
Demand
Bookings & conversion
Management expresses confidence about hitting LRP targets, with a robust new product pipeline, strong commercial execution, and continued margin expansion despite headwinds.
Tone · Confident
Management repeatedly emphasized momentum, execution, and faster-than-expected progress toward long-range targets, while maintaining full-year guidance.
Supply-chain alpha
A1
Solventum is pulling forward over $100M of sales from Q3 into Q2 as a mitigation strategy ahead of their last major ERP cutover in the US/Canada.
“we are estimating over 100 million additional sales in Q2 as we're working with our customers and distributors to advance orders before we begin our Q3 cutover of ERPs in the US and Canada.”